[Event Report] WHO Regional Committee for the Western Pacific Related Event: “AMR: A Global Health Crisis” (September 25, 2021)
date : 4/13/2022
Tags: AMR
![[Event Report] WHO Regional Committee for the Western Pacific Related Event: “AMR: A Global Health Crisis” (September 25, 2021)](https://hgpi.org/en/wp-content/uploads/sites/2/amr-event-20210925-1-top.jpg)
*A video of the Symposium has been published on April 13, 2022.
*A report on the Symposium has been published on April 2, 2022.
AMR Alliance Japan (Secretariat: Health and Global Policy Institute) hosted a WHO Regional Committee for the Western Pacific Related Event: “AMR: A Global Health Crisis”
Antimicrobial resistance (AMR) occurs when the microorganisms that cause infectious disease grow resistant over time to the antimicrobials used to treat them. If not enough is done to combat this problem, it is estimated that AMR will cause more deaths than cancer by 2050. Urgent action is needed.
In celebration of the 72nd session of the WHO Regional Committee for the Western Pacific to be held in Himeji in October, this symposium shared the current state of AMR-related issues within Japan and overseas, and discussed future countermeasures.
You can watch the day’s proceedings below.
[Overview]
■Date and Time: Saturday, September 25, 2021, from 16:00-18:00 JST
■Language: Japanese and English (Simultaneous Interpretation will be available)
■Venue:
– Online Participation (Zoom Webinar)
– Himeji Venue
■Participation fee: Free
■Organizers: AMR Alliance Japan, Himeji City, Himeji Medical Association, Himeji Dental Association
■Supported by: Ministry of Health, Labour and Welfare (TBD), Himeji Pharmacist Association, Hyogo Nursing Association Seiban Branch
■Sponsor: Japan Pharmaceutical Manufacturers Association
[Program] (Titles Omitted)
15:50-15:55 Greetings (For Himeji Venue Only)
Etsuji Ishibashi (Chairman, Himeji Medical Association)
16:00-16:05 Opening Remarks and Introduction
Ryoji Noritake (CEO, Boad Member, Health and Global Policy Institute)
16:05-16:25 Message
Takeshi Kasai (Regional Director for the Western Pacific, World Health Organization (WHO) )
Yasuhisa Shiozaki (Member of the House of Representatives; Former Minister of Health, Labour and Welfare; Member, Global Leaders Group on Antimicrobial Resistance; Chairman, Special Mission Committee on Data Health Advancement, Liberal Democratic Party of Japan(LDP))
Shigeru Omi (President, Japan Community Health care Organization (JCHO); Chairperson, Committee for the Promotion of Pandemic Influenza and New Infectious Disease Preparedness and Response)
16:25-16:40 Lecture 1 “AMR as a Global Health Crisis: A message from the United Kingdom”
Dame Sally Davies (UK Special Envoy on Antimicrobial Resistance)
16:40-16:55 Lecture 2 “AMR in Japan and Expectations toward Future”
Norio Ohmagari (Disease Control and Prevention Center, National Center for Global Health and Medicine (NCGM); Director, AMR Clinical Reference Center, NCGM)
16:55-17:55 Panel Discussion: Antimicrobial Stewardship
Panelists:
Socorro Escalante (Regional Coordinator for the programme on Essential Medicines and Health Technologies (EMT) and antimicrobial resistance (AMR), Western Pacific Regional Office, WHO)
Norio Ohmagari (Disease Control and Prevention Center, National Center for Global Health and Medicine (NCGM); Director, AMR Clinical Reference Center, NCGM)
Testuji Kawamura (Director, NHO Himeji Medical Center)
Kyoko Ama (Representative, Children and Healthcare Project; Fellow, Health and Global Policy Institute)
Takeshi Enami (Director, Tuberculosis and Infectious Diseases Control Division, Health Service Bureau, Ministry of Health, Labour and Welfare)
Hajime Inoue (Assistant Minister for Global Health and Welfare, Ministry of Health, Labour and Welfare)
Tetsuya Ito (Chair, International Affairs Committee, Japan Pharmaceutical Manufacturers Association)
Moderator:
Ryoji Noritake (CEO, Boad Member, Health and Global Policy Institute)
17:55 -18:00 Closing Remarks
Hideyasu Kiyomoto (Mayor of Himeji City)
Top Research & Recommendations Posts
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Public Comment Submission] “GX2040 Vision (Draft)” (January 26, 2025)
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Public Comment Submission] “Third Phase of The Healthcare Policy (Draft)” (February 3, 2025)
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Policy Recommendations] Achieving a Sustainable Society of Health and Longevity Through the Integration of Environment and Healthcare-Incorporating a Planetary Health Perspective into the 3rd Phase of The Healthcare Policy-(December 20, 2024)
- [Publication Report] Guidance on Patient and Public Involvement (PPI) in Health Policymaking: Necessary Initiatives and Good Examples from the Public and Government (March 31, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
Featured Posts
-
2025-02-12
[Registration Open] (Webinar) The 131st HGPI Seminar “The Policy Process of the Kyoto City Caregiver Ordinance” (March 19, 2025)
-
2025-03-03
[Registration Open] (Webinar) HGPI Special Seminar “Insights from Harvard Students on Fukushima’s Recover” (March 21, 2025 EDT | March 22, 2025 JST)
-
2025-03-17
[Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
-
2025-03-17
[Announcement] HGPI Participates in the WHO Civil Society Commission (March 17, 2025)
-
2025-03-17
[Policy Recommendations] Dementia Project Information Packet for Local Government Officials “Dementia Policies for Our City: Taking the First Step in Promoting Future Measures for Dementia” (March 17, 2025)